| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.14e-11 | 11 | 40 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.92e-11 | 14 | 40 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.69e-11 | 37 | 40 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.15e-10 | 38 | 40 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.95e-10 | 21 | 40 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.04e-08 | 37 | 40 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.19e-08 | 38 | 40 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.21e-08 | 46 | 40 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.84e-07 | 136 | 40 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.03e-07 | 79 | 40 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | nuclease activity | 6.21e-06 | 231 | 40 | 6 | GO:0004518 | |
| GeneOntologyMolecularFunction | endonuclease activity | 7.40e-06 | 136 | 40 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.27e-05 | 152 | 40 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.27e-05 | 262 | 40 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.06e-05 | 430 | 40 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.86e-05 | 654 | 40 | 8 | GO:0008233 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.68e-04 | 417 | 40 | 6 | GO:0140098 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.62e-04 | 645 | 40 | 7 | GO:0140640 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.28e-04 | 891 | 40 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.87e-04 | 18 | 40 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.23e-03 | 26 | 40 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.43e-03 | 28 | 40 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.77e-03 | 891 | 40 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.15e-03 | 1189 | 40 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.49e-03 | 37 | 40 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.80e-03 | 343 | 40 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.83e-03 | 171 | 40 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.87e-03 | 52 | 40 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 5.07e-03 | 807 | 40 | 6 | GO:0016788 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.06e-11 | 13 | 38 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 8.80e-09 | 83 | 38 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.61e-08 | 48 | 38 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 8.33e-07 | 178 | 38 | 6 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 2.71e-06 | 218 | 38 | 6 | GO:0071897 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.78e-05 | 85 | 38 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.78e-05 | 85 | 38 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | DNA replication | 2.10e-05 | 312 | 38 | 6 | GO:0006260 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.14e-05 | 89 | 38 | 4 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA recombination | 5.28e-05 | 368 | 38 | 6 | GO:0006310 | |
| GeneOntologyBiologicalProcess | DNA repair | 1.58e-04 | 648 | 38 | 7 | GO:0006281 | |
| GeneOntologyBiologicalProcess | DNA damage response | 2.99e-04 | 959 | 38 | 8 | GO:0006974 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 8.95e-05 | 8 | 38 | 2 | GO:0030991 | |
| Domain | Ion_trans_dom | 4.70e-05 | 114 | 33 | 4 | IPR005821 | |
| Domain | Ion_trans | 4.70e-05 | 114 | 33 | 4 | PF00520 | |
| Domain | Dynein_heavy_dom-1 | 8.42e-05 | 8 | 33 | 2 | IPR013594 | |
| Domain | DHC_N1 | 8.42e-05 | 8 | 33 | 2 | PF08385 | |
| Domain | Channel_four-helix_dom | 1.38e-04 | 57 | 33 | 3 | IPR027359 | |
| Domain | - | 1.38e-04 | 57 | 33 | 3 | 1.20.120.350 | |
| Domain | ATPase_dyneun-rel_AAA | 2.72e-04 | 14 | 33 | 2 | IPR011704 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.72e-04 | 14 | 33 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.72e-04 | 14 | 33 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.72e-04 | 14 | 33 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.72e-04 | 14 | 33 | 2 | PF08393 | |
| Domain | MT | 2.72e-04 | 14 | 33 | 2 | PF12777 | |
| Domain | AAA_8 | 2.72e-04 | 14 | 33 | 2 | PF12780 | |
| Domain | AAA_5 | 2.72e-04 | 14 | 33 | 2 | PF07728 | |
| Domain | DHC_fam | 3.13e-04 | 15 | 33 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.13e-04 | 15 | 33 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.13e-04 | 15 | 33 | 2 | PF03028 | |
| Domain | AAA+_ATPase | 2.07e-03 | 144 | 33 | 3 | IPR003593 | |
| Domain | AAA | 2.07e-03 | 144 | 33 | 3 | SM00382 | |
| Domain | ARM-type_fold | 2.88e-03 | 339 | 33 | 4 | IPR016024 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.45e-11 | 94 | 40 | 7 | 21542922 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 36256480 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 5.63e-09 | 4 | 40 | 3 | 10469592 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 7983737 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.41e-08 | 5 | 40 | 3 | 12629516 | |
| Pubmed | 3.08e-07 | 12 | 40 | 3 | 14557543 | ||
| Pubmed | 6.35e-07 | 15 | 40 | 3 | 38942786 | ||
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 18664271 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 33560657 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 37783116 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 18768809 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 31429973 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 27052477 | ||
| Pubmed | Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma. | 1.29e-06 | 2 | 40 | 2 | 21239045 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.29e-06 | 2 | 40 | 2 | 9460924 | |
| Pubmed | 1.35e-06 | 19 | 40 | 3 | 22398208 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 9971820 | ||
| Pubmed | E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. | 3.87e-06 | 3 | 40 | 2 | 28137882 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 10516026 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 22955108 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 21695255 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 27188501 | ||
| Pubmed | Spatiotemporal regulation of liver development by the Wnt/β-catenin pathway. | 7.73e-06 | 4 | 40 | 2 | 29426940 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 36140829 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 21062985 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 19995909 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.29e-05 | 5 | 40 | 2 | 11401426 | |
| Pubmed | Dual-color click beetle luciferase heteroprotein fragment complementation assays. | 1.29e-05 | 5 | 40 | 2 | 20851351 | |
| Pubmed | Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion. | 1.29e-05 | 5 | 40 | 2 | 24462873 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 26909801 | ||
| Pubmed | 1.35e-05 | 40 | 40 | 3 | 32317081 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 26180201 | ||
| Pubmed | Islet1-mediated activation of the β-catenin pathway is necessary for hindlimb initiation in mice. | 1.93e-05 | 6 | 40 | 2 | 21937598 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 33347437 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 15063128 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 25897075 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 22871496 | ||
| Pubmed | DAP-1, a novel protein that interacts with the guanylate kinase-like domains of hDLG and PSD-95. | 2.70e-05 | 7 | 40 | 2 | 9286858 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 30713111 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 31178125 | ||
| Pubmed | AP-2α is required after lens vesicle formation to maintain lens integrity. | 3.60e-05 | 8 | 40 | 2 | 24753151 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 34620853 | ||
| Pubmed | Generation of Mice with Hepatocyte-Specific Conditional Deletion of Notum. | 4.62e-05 | 9 | 40 | 2 | 26974334 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 39052671 | ||
| Pubmed | Alix is required during development for normal growth of the mouse brain. | 4.62e-05 | 9 | 40 | 2 | 28322231 | |
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 17478428 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 12970426 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 36791722 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 20084116 | ||
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 24857653 | ||
| Pubmed | Intrinsic neural stem cell properties define brain hypersensitivity to genotoxic stress. | 8.45e-05 | 12 | 40 | 2 | 35623353 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 8.99e-05 | 75 | 40 | 3 | 15372022 | |
| Pubmed | 9.11e-05 | 1285 | 40 | 8 | 35914814 | ||
| Pubmed | mTORC1 signaling and primary cilia are required for brain ventricle morphogenesis. | 9.98e-05 | 13 | 40 | 2 | 27993979 | |
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 28472653 | ||
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 25285789 | ||
| Pubmed | Brain milieu induces early microglial maturation through the BAX-Notch axis. | 1.16e-04 | 14 | 40 | 2 | 36253375 | |
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 37371026 | ||
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 28552735 | ||
| Pubmed | Identification of NeuN immunopositive cells in the adult mouse subventricular zone. | 1.53e-04 | 16 | 40 | 2 | 29752725 | |
| Pubmed | Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex. | 1.53e-04 | 16 | 40 | 2 | 25425146 | |
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 31823782 | ||
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 34052210 | ||
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 26025376 | ||
| Pubmed | 1.83e-04 | 246 | 40 | 4 | 15345747 | ||
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 24424161 | ||
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 33462112 | ||
| Pubmed | Wnt/β-catenin promotes gastric fundus specification in mice and humans. | 1.95e-04 | 18 | 40 | 2 | 28052057 | |
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 27392482 | ||
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 33323119 | ||
| Pubmed | Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models. | 2.18e-04 | 19 | 40 | 2 | 23744272 | |
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 32579270 | ||
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 36916004 | ||
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 30699346 | ||
| Pubmed | Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development. | 2.18e-04 | 19 | 40 | 2 | 35173232 | |
| Pubmed | Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. | 2.42e-04 | 20 | 40 | 2 | 26033091 | |
| Pubmed | 2.42e-04 | 20 | 40 | 2 | 18231602 | ||
| Pubmed | Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. | 2.67e-04 | 21 | 40 | 2 | 23637172 | |
| Pubmed | ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. | 2.67e-04 | 21 | 40 | 2 | 30985297 | |
| Pubmed | Wnt3a links left-right determination with segmentation and anteroposterior axis elongation. | 2.67e-04 | 21 | 40 | 2 | 16291790 | |
| Pubmed | 2.94e-04 | 22 | 40 | 2 | 17150208 | ||
| Pubmed | 2.94e-04 | 22 | 40 | 2 | 29249622 | ||
| Pubmed | 2.94e-04 | 22 | 40 | 2 | 17919533 | ||
| Pubmed | mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. | 3.21e-04 | 23 | 40 | 2 | 22017875 | |
| Pubmed | Cd9 Protects Photoreceptors from Injury and Potentiates Edn2 Expression. | 3.21e-04 | 23 | 40 | 2 | 32150249 | |
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 36103829 | ||
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 37873566 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 3.35e-04 | 824 | 40 | 6 | 20237496 | |
| Pubmed | DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma. | 3.50e-04 | 24 | 40 | 2 | 32553121 | |
| Pubmed | mTORC1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux. | 3.80e-04 | 25 | 40 | 2 | 30340022 | |
| Pubmed | Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality. | 4.45e-04 | 27 | 40 | 2 | 28542142 | |
| Pubmed | 5.50e-04 | 30 | 40 | 2 | 22056141 | ||
| Pubmed | 5.87e-04 | 31 | 40 | 2 | 22228100 | ||
| Pubmed | 5.87e-04 | 31 | 40 | 2 | 36656901 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 6.66e-04 | 33 | 40 | 2 | 22357600 | |
| Pubmed | mTOR acts as a pivotal signaling hub for neural crest cells during craniofacial development. | 6.66e-04 | 33 | 40 | 2 | 29975682 | |
| Pubmed | 7.07e-04 | 34 | 40 | 2 | 26378152 | ||
| Pubmed | 7.07e-04 | 34 | 40 | 2 | 32866472 | ||
| Pubmed | The transcription factor RBP-J is essential for retinal cell differentiation and lamination. | 7.07e-04 | 34 | 40 | 2 | 20017954 | |
| Interaction | GLUL interactions | 2.55e-07 | 160 | 34 | 6 | int:GLUL | |
| Cytoband | 2p24.1 | 1.76e-04 | 23 | 39 | 2 | 2p24.1 | |
| Cytoband | 16p13.3 | 1.18e-03 | 244 | 39 | 3 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p24 | 2.18e-03 | 81 | 39 | 2 | chr2p24 | |
| GeneFamily | Dyneins, axonemal | 2.46e-04 | 17 | 25 | 2 | 536 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 4.97e-04 | 24 | 25 | 2 | 615 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-06 | 169 | 33 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.08e-05 | 187 | 33 | 4 | 55d5b21517c89736592982af40fd4cd64be62a3c | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.15e-05 | 190 | 33 | 4 | 9db04555c98eca1df15d144fbb499e0ba06660d5 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 1.22e-05 | 193 | 33 | 4 | e7d2833ad48e4db547d046514036948c58c01dde | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-05 | 195 | 33 | 4 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.27e-05 | 195 | 33 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.40e-05 | 200 | 33 | 4 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-05 | 200 | 33 | 4 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-05 | 200 | 33 | 4 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-05 | 200 | 33 | 4 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-05 | 200 | 33 | 4 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.77e-04 | 148 | 33 | 3 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 148 | 33 | 3 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 148 | 33 | 3 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.03e-04 | 155 | 33 | 3 | 03fd443740272dcb547e39deaf7ae89b8307f241 | |
| ToppCell | COPD-Epithelial-PNEC|COPD / Disease state, Lineage and Cell class | 2.19e-04 | 159 | 33 | 3 | 6018124980c55190928409f3bf41d846a118954a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.27e-04 | 161 | 33 | 3 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 164 | 33 | 3 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-04 | 164 | 33 | 3 | f2b4d69ee994977275db5ad6d38f681cfe827db0 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-04 | 166 | 33 | 3 | da10d0be6b616199d49dd922591c2901f9681583 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 168 | 33 | 3 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.61e-04 | 169 | 33 | 3 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-04 | 171 | 33 | 3 | b520d4d5620cac08315e4cbb7e796c5e9e233060 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.75e-04 | 172 | 33 | 3 | 968d18ab8c3cdeb7936a2aa721a7f41525763863 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 173 | 33 | 3 | b9dc42d629d13e63aada5ae49ba0cbb0952c5fe9 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-04 | 174 | 33 | 3 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 3.09e-04 | 179 | 33 | 3 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.09e-04 | 179 | 33 | 3 | 140dd7dbac48f5f07279f31bf971d7fbd41fa18b | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.25e-04 | 182 | 33 | 3 | bfab19f855c4a595f7d652d43f159f0fcd8d56d1 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-04 | 182 | 33 | 3 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 182 | 33 | 3 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-04 | 183 | 33 | 3 | c289a257918aa660db8657810b3c4881382d56f3 | |
| ToppCell | tumor_Lung-Myeloid_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 3.30e-04 | 183 | 33 | 3 | 7ef79365514e62dfc2e182e873e2b413d4f46b46 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-04 | 184 | 33 | 3 | 97ae5ffecf90df42cc8eea2a247ca589f35a4783 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 3.35e-04 | 184 | 33 | 3 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac|bone_marrow / Manually curated celltypes from each tissue | 3.52e-04 | 187 | 33 | 3 | 99f39818b896032957fe123936d9e1877311c42e | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 187 | 33 | 3 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.52e-04 | 187 | 33 | 3 | 88fac9f23047892acccbcc355d02ff079596fedf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.57e-04 | 188 | 33 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 188 | 33 | 3 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 188 | 33 | 3 | fcf1bebef7aa81b4a11c1f9e4319339c290ecd22 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 188 | 33 | 3 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 189 | 33 | 3 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.63e-04 | 189 | 33 | 3 | cce6602ad68c177985a5e43cfb2776d615cfbca0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 189 | 33 | 3 | b491204cf38dc80a2583e3082a82dda8d77b3fc4 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-APOE+_Mac2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.63e-04 | 189 | 33 | 3 | e189ef6066f87177d758f0e3ed9a17e01031a391 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-04 | 189 | 33 | 3 | 131a36e2c900b3b22ba920e0658815e8e278e87d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 189 | 33 | 3 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 189 | 33 | 3 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.63e-04 | 189 | 33 | 3 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.63e-04 | 189 | 33 | 3 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 3.68e-04 | 190 | 33 | 3 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 190 | 33 | 3 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-04 | 190 | 33 | 3 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-04 | 190 | 33 | 3 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 3.74e-04 | 191 | 33 | 3 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-04 | 191 | 33 | 3 | 87b974a320888d63aa8cefcd8dc97d525b56d848 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-04 | 191 | 33 | 3 | bd0f8adfb2a508babee73477d0e9300330471e7a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.74e-04 | 191 | 33 | 3 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.80e-04 | 192 | 33 | 3 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | URO|World / Disease, Lineage and Cell Type | 3.86e-04 | 193 | 33 | 3 | 421dc0996c6c973f88e90197b651255ae4dd13a2 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.86e-04 | 193 | 33 | 3 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 3.86e-04 | 193 | 33 | 3 | 6e9912f5444c591e698b9a7ffa3e9fc3d8ee57b0 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.86e-04 | 193 | 33 | 3 | 47249aabdd912052aa635d276eed20d32b525393 | |
| ToppCell | COPD-Myeloid|COPD / Disease state, Lineage and Cell class | 3.86e-04 | 193 | 33 | 3 | f58552e286aa27e592497ad78776f58f8ee09841 | |
| ToppCell | myeloid-macrophage|World / Lineage and Cell class | 3.86e-04 | 193 | 33 | 3 | b13e694123b87ed8ad1786feb996398ddd84e94b | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.92e-04 | 194 | 33 | 3 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.92e-04 | 194 | 33 | 3 | 4f28841c7f37884fc34c6689cd6976c6559d23f1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Myeloid-Microglia|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.92e-04 | 194 | 33 | 3 | 459e836bcdb6742333684ac23d960efa5e99702f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-04 | 194 | 33 | 3 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 3.92e-04 | 194 | 33 | 3 | 40dbfdf1d7e6b73d120d8f802f08e573fe9a739e | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.92e-04 | 194 | 33 | 3 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-04 | 194 | 33 | 3 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-04 | 195 | 33 | 3 | c16479a10f5ca2e89aea1742dbc5cc4dc9f3ea88 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.97e-04 | 195 | 33 | 3 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 3.97e-04 | 195 | 33 | 3 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-04 | 195 | 33 | 3 | 028622b234551b185977fbee10c06851a45456a5 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.97e-04 | 195 | 33 | 3 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-04 | 195 | 33 | 3 | 5a7c74f96f213c504abd65e751800da7e03e47d9 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-04 | 195 | 33 | 3 | 9231e929657542b78a6480d44402866511129c7f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | ec218ae03ebf8588996e86d6d9a8ea3cf71affaa | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.03e-04 | 196 | 33 | 3 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.03e-04 | 196 | 33 | 3 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.03e-04 | 196 | 33 | 3 | 6038c566c58a24b3582011344039e16ff0dda95f | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-04 | 196 | 33 | 3 | 88517bb92be2f05c1e1ad94af22ac10d8c5c13c7 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-04 | 196 | 33 | 3 | 03710e2a843279124a45a271bffb132835e6081c | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.03e-04 | 196 | 33 | 3 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.09e-04 | 197 | 33 | 3 | 8736f1d446db3eb28a99997a9a683ded8e18e4c6 | |
| ToppCell | (3)_Macrophage_MARCOneg|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.09e-04 | 197 | 33 | 3 | b0ee2ce1179b60b4542559acb300a34295277dbc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-04 | 197 | 33 | 3 | 61f2c420b77d0527d57532172b07bfb7a4cf971a | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-04 | 197 | 33 | 3 | 72775eb6c24cfb956436642ac9cd6e4d5c01ea5f | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.09e-04 | 197 | 33 | 3 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Luminal_Macrophages|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.09e-04 | 197 | 33 | 3 | 523a7f363c7ba8c196ea6e4f7544c29c18c10b51 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.09e-04 | 197 | 33 | 3 | 5e4a004052b8560223673a339d4a0d729e533def | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 6.93e-06 | 181 | 34 | 5 | 1537_UP | |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 9.71e-06 | 194 | 34 | 5 | 2776_UP | |
| Disease | temporal lobe epilepsy (implicated_via_orthology) | 3.83e-05 | 9 | 31 | 2 | DOID:3328 (implicated_via_orthology) | |
| Disease | Lymphoma, Lymphocytic, Intermediate | 5.84e-05 | 11 | 31 | 2 | C0751958 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.27e-04 | 16 | 31 | 2 | C0334634 | |
| Disease | Liver carcinoma | 1.72e-04 | 507 | 31 | 5 | C2239176 | |
| Disease | Left Ventricular Hypertrophy | 3.16e-04 | 25 | 31 | 2 | C0149721 | |
| Disease | migraine disorder, glucose measurement | 4.87e-04 | 31 | 31 | 2 | EFO_0004468, MONDO_0005277 | |
| Disease | Colonic Neoplasms | 5.42e-04 | 152 | 31 | 3 | C0009375 | |
| Disease | cervical cancer | 5.87e-04 | 34 | 31 | 2 | C4048328 | |
| Disease | cognitive function measurement | 5.93e-04 | 1434 | 31 | 7 | EFO_0008354 | |
| Disease | Malignant tumor of colon | 6.18e-04 | 159 | 31 | 3 | C0007102 | |
| Disease | Uterine Cervical Neoplasm | 6.22e-04 | 35 | 31 | 2 | C0007873 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RFTYHMVSGMSLRPR | 191 | O71037 | |
| RFTYHMVSGMSLRPR | 191 | Q902F8 | |
| YRSDRLMSFRPIKMD | 131 | P53674 | |
| AMRPDRMTYALRNFV | 3886 | Q96DT5 | |
| SPKFRSRNESYMRAM | 431 | O14490 | |
| MRSMRKTFARYLSFR | 811 | P49736 | |
| YAMTRAQRVRAAMFP | 86 | P35222 | |
| MSFFFVDLRPMNRSA | 1 | Q8NGC9 | |
| FAAPSRYRFIRSVMS | 246 | Q9UK17 | |
| MVSMSFKRNRSDRFY | 1 | Q15012 | |
| MYRLMSAVTARAAAP | 1 | P83111 | |
| LFYGAAMFMYLRPRR | 251 | Q8NHB1 | |
| AMFMYLRPRRYRAPS | 256 | Q8NHB1 | |
| MLQPFMFRLDSQYRA | 476 | P11678 | |
| REMFNPMYALFRTSP | 4071 | Q7Z6Z7 | |
| RFTYHMVSGMSLRPR | 951 | P63135 | |
| PAMMFASRLTAYFRR | 331 | O15440 | |
| RFTYHMVSGMSLRPR | 191 | P61570 | |
| RFTYHMVSGMSLRPR | 191 | Q69384 | |
| SFSSPEMLRSRYLMY | 941 | Q5TEA3 | |
| RFTYHMVSGMSLRPR | 191 | Q902F9 | |
| AMRPDRMTYALRDFV | 3856 | Q9NYC9 | |
| VSRMLSLPNDSYMFR | 1921 | O95180 | |
| MAASRPFFRDIVFYM | 196 | Q6J4K2 | |
| FYPAVSMVALMRIFR | 946 | P42345 | |
| DMYLVPAAMFRDPFR | 76 | P15104 | |
| DRPFRMMLHAFYLRI | 201 | Q9UJJ7 | |
| ATFQRNRYPDMSMRE | 106 | P78337 | |
| FMMSLYRSLAGRAPA | 91 | Q7Z4P5 | |
| RDARMSDAGRYFFRM | 111 | Q9Y286 | |
| TMFFQYLLQPFRAMR | 236 | Q8TF30 | |
| FSFAAMLMRPEYRSK | 1211 | Q8NEZ3 | |
| DLLMYLRAARSMAAF | 326 | Q9P2R6 | |
| FSYPDFLRMMLGKRS | 101 | P55008 | |
| SLRMMGFTCFYKRRT | 311 | Q9UNK9 | |
| PMFRANRMLKYTSFF | 321 | Q9NQW8 | |
| LRNFTEMMRALGYPR | 6 | Q96AJ1 | |
| RFTYHMVSGMSLRPR | 951 | P10266 | |
| RFTYHMVSGMSLRPR | 951 | Q9UQG0 | |
| PRILSFNTMRYTFNM | 2081 | Q70CQ2 | |
| RRSRSPMHYMYRPRS | 506 | Q14966 | |
| RFTTFPRAFMSMFQI | 536 | Q8IZF0 |